Login / Signup

Effectiveness of emicizumab in preventing life-threatening bleeding complications in type 3 von Willebrand disease with inhibitors: A paediatric report.

Maria Giuseppina CefaloFrancesca RoncoGiovina Di FeliceMartina RinelliVincenzo OrianaMichela MassoudPietro MerliMatteo Luciani
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Keyphrases
  • randomized controlled trial
  • intensive care unit
  • systematic review
  • emergency department
  • atrial fibrillation
  • risk factors